Substance guides
Nicotine addiction treatment: Beyond patches and gum
Nicotine is one of the most addictive substances known, yet nicotine dependence is often treated as a minor habit rather than a clinical addiction. Most quit attempts using willpower alone fail within a week. Evidence-based treatment dramatically improves quit rates, and the options have expanded well beyond patches and gum.
Prescription medications
Varenicline (Chantix) is the most effective single medication for smoking cessation, approximately tripling quit rates compared to placebo. It works by partially activating nicotine receptors — reducing cravings while blocking the rewarding effects of smoking. Bupropion (Wellbutrin, Zyban) is an antidepressant that also reduces nicotine cravings and withdrawal symptoms. It is particularly useful for people with co-occurring depression. Combination therapy using both a nicotine replacement product (patch for baseline coverage) and a short-acting product (gum or lozenge for breakthrough cravings) is more effective than either alone.
Behavioral treatment
Medications are most effective when combined with behavioral support. Evidence-based behavioral approaches include CBT focused on identifying and managing smoking triggers, motivational interviewing to strengthen commitment to quitting, telephone quit lines (1-800-QUIT-NOW is free in every state), and digital therapeutics — FDA-cleared apps and programs that deliver structured quit support through your phone. Group programs offered through hospitals and community organizations provide peer support and accountability.
When nicotine addiction co-occurs with other issues
Nicotine addiction frequently co-occurs with other substance use disorders and mental health conditions. Smoking rates among people with alcohol use disorder, opioid use disorder, and severe mental illness are 2-4 times higher than the general population. Historically, treatment programs avoided addressing nicotine — "one thing at a time" — but current evidence shows that quitting smoking during or shortly after addiction treatment does not increase relapse risk for other substances and may actually improve recovery outcomes.